Advertisement
Screener

Deciphera Pharmaceuticals, Inc. Patents: Applications Pending, 2022

Deciphera Pharmaceuticals, Inc. Patent Applications Pending

20 applications still open at the USPTO, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2022-12-23: Application 63435137; Invention METHODS OF TREATING GASTROINTESTINAL STROMAL TUMORS; Applicant Deciphera Pharmaceuticals, LLC; Status Provisional Application Expired.
  • 2022-12-09: Application PCTUS2022081242; Invention RAF KINASE INHIBITORS AND METHODS OF USE THEREOF; Applicant DECIPHERA PHARMACEUTICALS, LLC; Status RO PROCESSING COMPLETED-PLACED IN STORAGE.
  • 2022-12-09: Application PCTUS2022081236; Invention RAF KINASE INHIBITORS AND METHODS OF USE THEREOF; Applicant DECIPHERA PHARMACEUTICALS, LLC; Status RO PROCESSING COMPLETED-PLACED IN STORAGE.
  • 2022-12-09: Application 18078269; Invention RAF KINASE INHIBITORS AND METHODS OF USE THEREOF; Applicant Deciphera Pharmaceuticals, LLC; Status Final Rejection Mailed.
FiledApplicationInventionApplicantStatusPublished asInventor nameInventor countryExaminer
2022-12-2363435137METHODS OF TREATING GASTROINTESTINAL STROMAL TUMORSDeciphera Pharmaceuticals, LLCProvisional Application Expired
Kam M. Sprott
Matthew L. Sherman
Rodrigo Ruiz Soto
United States
United States
United States
2022-12-09PCTUS2022081242RAF KINASE INHIBITORS AND METHODS OF USE THEREOFDECIPHERA PHARMACEUTICALS, LLCRO PROCESSING COMPLETED-PLACED IN STORAGE
DANIEL L. FLYNN
YU MI AHN
LAKSHMINARAYANA VOGETI
BERTRAND LE BOURDONNEC
United States
United States
United States
United States
2022-12-09PCTUS2022081236RAF KINASE INHIBITORS AND METHODS OF USE THEREOFDECIPHERA PHARMACEUTICALS, LLCRO PROCESSING COMPLETED-PLACED IN STORAGE
CHASE KENYON CRAWLEY
DANIEL L. FLYNN
YU MI AHN
LAKSHMINARAYANA VOGETI
BERTRAND LE BOURDONNEC
United States
United States
United States
United States
United States
2022-12-0918078269RAF KINASE INHIBITORS AND METHODS OF USE THEREOFDeciphera Pharmaceuticals, LLCFinal Rejection MailedUS20230357179A1
Daniel L. Flynn
Yu Mi Ahn
Lakshminarayana Vogeti
Bertrand Le Bourdonnec
United States
United States
United States
United States
ENGLISH, CONNOR KENNEDY
2022-12-02PCTUS2022080828KIT KINASE INHIBITORS AND METHODS OF USE THEREOFDECIPHERA PHARMACEUTICALS, LLCRO PROCESSING COMPLETED-PLACED IN STORAGE
YU MI AHN
TIMOTHY CALDWELL
DANIEL L. FLYNN
BERTRAND LE BOURDONNEC
United States
United States
United States
United States
2022-12-02PCTUS2022051717GCN2 AND PERK KINASE INHIBITORS AND METHODS OF USE THEREOFDECIPHERA PHARMACEUTICALS, LLCRO PROCESSING COMPLETED-PLACED IN STORAGE
YU MI AHN
GADA AL-ANI
DANIEL L. FLYNN
SALIM JAVED
PATRICK KEARNEY
BERTRAND LE BOURDONNEC
KRISTEN STOLTZ
JEFFERY ZWICKER
United States
United States
United States
United States
United States
United States
United States
United States
2022-12-0218073721KIT KINASE INHIBITORS AND METHODS OF USE THEREOFDeciphera Pharmaceuticals, LLCResponse to Non-Final Office Action Entered and Forwarded to ExaminerUS20240116877A1
Yu Mi Ahn
Timothy Caldwell
Daniel L. Flynn
Bertrand LeBourdonnec
United States
United States
United States
United States
VALLE, ERNESTO
2022-09-0263403477METHODS OF TREATING DISORDERS WITH ULK INHIBITORSDeciphera Pharmaceuticals, LLCProvisional Application Expired
Rodrigo Ruiz Soto
Fred J. Reu
Matthew L. Sherman
Daniel L. Flynn
Madhumita Bogdan
Bryan D. Smith
Gada Al-Ani
United States
United States
United States
United States
United States
United States
United States
2022-09-0263403444METHODS OF TREATING GASTROINTESTINAL STROMAL TUMORSDeciphera Pharmaceuticals, LLCProvisional Application Expired
Jing Wang
Xiaoyan LI
United States
United States
2022-09-0263403417ULK INHIBITORS AND METHODS OF USE THEREOFDeciphera Pharmaceuticals, LLCProvisional Application Expired
Justin T. Proto
Andrew Michael Harned
Kristen Stoltz
Timothy Caldwell
Lakshminarayana Vogeti
Yu Mi Ahn
Bertrand Le Bourdonnec
Daniel L. Flynn
United States
United States
United States
United States
United States
Oman
United States
United States
2022-09-0263374451METHODS OF TREATING DISORDERS WITH ULK INHIBITORSDeciphera Pharmaceuticals, LLCProvisional Application Expired
Rodrigo Ruiz Soto
Fred J. Reu
Matthew L. Sherman
Daniel L. Flynn
Madhumita Bogdan
Bryan D. Smith
Gada Al-Ani
United States
United States
United States
United States
United States
United States
United States
2022-08-12PCTUS2022074925COMBINATION THERAPY USING VPS34 INHIBITORSDECIPHERA PHARMACEUTICALS, LLCRO PROCESSING COMPLETED-PLACED IN STORAGE
YASMIN YU
MARTIN ANDERSSON
DANIEL L. FLYNN
MADHUMITA BOGDAN
United States
United States
United States
United States
2022-07-2963393445RAF KINASE INHIBITORS AND METHODS OF USE THEREOFDeciphera Pharmaceuticals, LLCProvisional Application Expired
Daniel L. Flynn
Yu Mi Ahn
Lakshminarayana Vogeti
Bertrand Le Bourdonnec
United States
United States
United States
United States
2022-07-2963393440RAF KINASE INHIBITORS AND METHODS OF USE THEREOFDeciphera Pharmaceuticals, LLCProvisional Application Expired
Daniel L. Flynn
Yu Mi Ahn
Lakshminarayana Vogeti
Bertrand Le Bourdonnec
United States
United States
United States
United States
2022-06-2117845275USE OF 1-[4-BROMO-5-[1-ETHYL-7-(METHYLAMINO)-2-OXO-1,2-DIHYDRO-1,6-NAPHTHYRIDIN-3-YL]-2-FLUOROPHENYL]-3-PHENYLUREA AND ANALOGS FOR THE TREATMENT OF CANCERS ASSOCIATED WITH GENETIC ABNORMALITIES IN PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHADeciphera Pharmaceuticals, LLCFinal Rejection MailedUS20220370423A1
Daniel L. Flynn
Michael D. Kaufman
Oliver Rosen
Bryan D. Smith
United States
United States
United States
United States
RODRIGUEZ, RAYNA B
2022-06-0363348557GCN2 AND PERK KINASE INHIBITORS AND METHODS OF USE THEREOFDeciphera Pharmaceuticals, LLCProvisional Application Expired
Yu Mi Ahn
Gada Al-Ani
Daniel L. Flynn
Salim Javed
Patrick Kearney
Bertrand LeBourdonnec
Kristen Stoltz
Jeffery Zwicker
United States
United States
United States
United States
United States
United States
United States
United States
2022-05-10PCTUS2022028456METHODS OF TREATING MELANOMA WITH RIPRETINIBDECIPHERA PHARMACEUTICALS, LLCRO PROCESSING COMPLETED-PLACED IN STORAGE
YING SU
RODRIGO RUIZ SOTO
United States
United States
2022-04-1163329674KIT KINASE INHIBITORS AND METHODS OF USE THEREOFDeciphera Pharmaceuticals, LLCProvisional Application Expired
Yu Mi Ahn
Timothy Caldwell
Daniel L. Flynn
Bertrand LeBourdonnec
United States
United States
United States
United States
2022-03-0763317500COMBINATION THERAPY USING VPS34 INHIBITORSDeciphera Pharmaceuticals, LLCProvisional Application Expired
Yasmin Yu
Martin Andersson
Daniel L. Flynn
Madhumita Bogdan
Sweden
Sweden
United States
United States
2022-02-2463313570METHODS OF TREATING MELANOMA WITH RIPRETINIBDeciphera Pharmaceuticals, LLCProvisional Application Expired
Rodrigo Ruiz Soto
Ying Su
United States
United States